YANA MURAKHOVSKY: Open Payments
NPI 1730544107 · WYLIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 26 payments from 10 companies in 2025. Trend: 2023 $252 · 2024 $683 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $163 |
| Lundbeck LLC | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Tris Pharma Inc | 2 | $38 |
| Corium, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, REXULTI, CAPLYTA, FANAPT, TRINTELLIX, Auvelity, Dyanavel XR, Azstarys.
Industry payments across TX — which companies pay providers there.
